News
Market and company headlines
Centene Q3 2026 results beat revenue and adjusted EPS estimates and raised 2026 guidance, but shares fell on a GAAP loss and profit-taking.

Investing.com -- Centene on Tuesday beat third-quarter profit estimates and raised its full-year outlook for both earnings and revenue, but its shares slipped about 2% in premarket trading.


Health coverage company Centene (NYSE:CNC) reported Q3 2026 results topping the market’s revenue expectations, with revenue rising 1.9% year on year to $50.65 billion. The company’s full-year revenue guidance of $198.5 billion at the midpoint came in 1.3% above analysts’ consensus estimates. Its non-GAAP profit of $0.58 per share was significantly above analysts’ consensus estimates.

Centene Corp. raised full-year adjusted EPS guidance to over $4.80, driven by improved Marketplace and Medicare Part D margins. Read why CNC stock is a buy.

Centene remains a Buy, supported by operational improvements, disciplined capital management, and a discounted valuation vs. sector averages. Learn more about CNC stock here.

Centene CEO Sarah London, the youngest-ever female chief executive of a Fortune 500 company, told Fortune MPW that she took on the role because she wanted to fix health care.

In October 2026, Centene Corporation announced a National Performance-Based Gold Card Program, set to begin in November 2026, to streamline prior authorization for more than 160,000 eligible providers, alongside plans to redeem all remaining US$568.66 million of its 4.25% Notes due 2027 and expand primary care access through an Ambetter Health Solutions collaboration with Marathon Health in select Indiana and Missouri counties. This combination of a performance-based prior authorization...
Shares of health coverage company Centene (NYSE:CNC) jumped 3.5% in the afternoon session after the company announced plans to launch its National Performance-Based Gold Card Program in November 2026 to simplify the prior authorization review process for healthcare providers.

Centene Corporation (NYSE: CNC) today announced it will launch its National Performance-Based Gold Card Program in November 2026. The program, which will initially be available to more than 160,000 qualifying providers nationwide for select outpatient services, is designed to streamline the prior authorization review process while maintaining appropriate clinical and quality standards.
Cambiar Opportunity Fund, managed by Cambiar Investors, published its Q2 2026 investor letter. The letter can be downloaded here. U.S. equity markets experienced a significant rebound in Q2, with the S&P 500 rising 15.2% and the Russell 2000 up 21.5%. Growth stocks outperformed value, although value retained a year-to-date lead. The market’s rise was fueled […]

TCW Funds, an investment management firm, published its second-quarter 2026 investor letter for the “TCW Relative Value Mid Cap Fund”. The letter can be downloaded here. Equities advanced in Q2 2026, with the S&P 500 reaching record highs despite volatility from a Federal Reserve leadership transition and Middle East tensions. Markets rebounded from Q1 lows, […]
CertifyOS, the company architecting the future of provider data infrastructure, today announced the launch of its National Shared Credentialing Program, a first-of-its-kind credentialing model that is designed to reduce redundancies and significantly streamline the provider verification and credentialing process. With initial participants including UnitedHealthcare, Cigna Healthcare, and Centene, providers will have a centralized credentialing home that is built to deliver measurable improvement

What a fantastic six months it’s been for Centene. Shares of the company have skyrocketed 94.3%, hitting $63.74. This was partly due to its solid quarterly results, and the performance may have investors wondering how to approach the situation.
Following Gov. Newsom's declaration of a State of Emergency statewide due to weather events and a sewage spill across California, Health Net, one of California's most experienced Medi-Cal managed care health plans and company of Centene Corporation (NYSE: CNC), is taking immediate action to support those affected. The company's priority is ensuring both its members and healthcare providers have the resources they need during this critical time.
Health Net, one of California's most experienced Medi-Cal managed care health plans and company of Centene Corporation (NYSE: CNC), announced a $3 million grant to Mutual Housing California to support the development of Fairview Terrace, a new affordable housing community for income-qualified seniors in Stockton.
Here is how Centene (CNC) and Alzamend Neuro, Inc. (ALZN) have performed compared to their sector so far this year.

Centene, BrightSpring and Delek combine 52-week gains with short-term pullbacks, putting them in focus as momentum plays for volatile markets.
Centene (CNC) has moved back into focus after being highlighted for its earnings expectations, an attractive valuation profile, and exposure to growing ICHRA-driven individual coverage through its Ambetter Health Solutions business. Centene’s recent momentum has been hard to ignore, with a 90 day share price return of 9.96% feeding into a 60.60% year to date gain and a 1 year total shareholder return of 108.58%. This suggests investors are reassessing both its earnings profile and perceived...

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Centene (CNC) shows a strong technical breakout setup: uptrend, tight consolidation, high ratings, and clear entry/stop levels.

SNDR, NESR and CNC made it to the Zacks Rank #1 (Strong Buy) growth stocks list on September 18th, 2026.
CNC's profitability is recovering, but rising margins face a key test as Medicaid membership declines and eligibility reviews continue.

Avnet, Centene, Signet and Lifetime Brands stand out as value plays as Fed tightening keeps focus on cash flow and discounted valuations.
CNC is set to reshape its Medicare Advantage business around dual-eligible members and a simpler footprint to drive margin recovery.

Discover the top S&P500 movers in Friday's pre-market session and stay informed about market dynamics.
Centene has outpaced the healthcare sector, and analysts remain moderately optimistic about the stock’s outlook.

CNC, ATI and SANM made it to the Zacks Rank #1 (Strong Buy) growth stocks list on September 10, 2026.
UnitedHealth (UNH) runs the best operating margin of the three managed care companies in its peer group, and the slowest revenue growth of the three. It also carries a significant valuation premium over its peer, Cigna, trading at more than double its earnings multiple.
Health Net, one of California's most experienced Medi-Cal managed care health plans and company of Centene Corporation (NYSE: CNC), today announced a $2 million investment in Stanislaus Equity Partners, Inc. (STEP) to help more residents access safe, stable, affordable housing. The multi-year grant will provide flexible gap financing for 50 affordable housing projects already in the local pipeline, helping move shovel-ready developments closer to completion.
UNH is investing nearly $1.5B in AI to expand Optum Insight's software offerings, boost efficiency and unlock new growth opportunities.
The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether these cheap assets are genuinely undervalued or simply on sale due to their potentially deteriorating business models.
Beazer Homes, Centene, HP, ChargePoint and Cracker Barrel stand out as broker-favored picks amid geopolitical tensions, inflation and market uncertainty.
Centene's Q2 adjusted EPS reached $2.51 and operating cash flow was $3.6 billion, supporting an increased 2026 revenue forecast. Read more on CNC stock here.

As the Q2 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the health insurance providers industry, including Centene (NYSE:CNC) and its peers.

Here is how Adicet Bio, Inc. (ACET) and Centene (CNC) have performed compared to their sector so far this year.
CNC, VLO, and MNDY it to the Zacks Rank #1 (Strong Buy) growth stocks list on September 3rd, 2026.
ST LOUIS (AP) — ST LOUIS (AP) — Centene Corp. (CNC) on Tuesday reported a loss of $71 million in its third quarter.





